Delivery apparatus and accompanying system for the application of a medical agent to a treatment site and method for use of same

1. A delivery apparatus for the application of a medical agent to a treatment site, the medication delivery apparatus comprising:

a housing, the housing being sized so as to be securable to a hand-held medical device;

a reservoir configured to contain the medical agent, the reservoir disposed in fluid communication with a supply channel and a circulation channel;

a nebulization housing including a lower chamber and an upper chamber;

the lower chamber being disposed in fluid communication with the supply channel and the circulation channel;

an upper channel being disposed in fluid communication with an airflow channel and a delivery channel;

an ultrasonic transducer positioned in the lower chamber, the ultrasonic transducer configured to generate, upon energization, ultrasonic energy;

a control valve interposed between a source of positive pressure air and the airflow channel, the control valve configured to selectively apply air to the airflow channel;

the reservoir, the supply channel, the circulation channel, the nebulization housing, the airflow channel, the delivery channel, and the control valve being located in the housing;

the control valve being controllable by a controller, the controller being externally positioned on the housing;

a first operational state of the control valve, wherein the control valve is open, wherein the medical agent is configured to circulate from the reservoir to the lower chamber, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to be carried by the application of air to the delivery channel; and

a second operational state of the control valve, wherein the control valve is closed, wherein the medical agent is configured to circulate from the reservoir to the lower chamber, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to remain in the upper chamber.

2. The delivery apparatus as recited in claim 1 , further comprising the medical agent, wherein the medical agent further comprises a local anesthetic.

3. The delivery apparatus as recited in claim 1 , further comprising the medical agent, wherein the medical agent local further comprises an agent selected from the group consisting of steroids, antibiotics, anti-fungal agents, anti-bacterial agents, antiviral agents, hormones, antihistamines, non-steroidal anti-inflammatories, glucocorticoids, corticosteroids, chemotherapeutic agents, and vasodilating anesthetics.

4. The delivery apparatus as recited in claim 1 , wherein the reservoir has a volume from about 5 ml to about 250 ml.

5. The delivery apparatus as recited in claim 1 , further comprising a heating element associated with the reservoir, the heating element configured to heat the medical agent.

6. The delivery apparatus as recited in claim 1 , further comprising a heating element associated with the reservoir, the heating element configured to heat the medical agent to a temperature from about 50° F. (10° C.) to about 105° F. (40.5° C.).

7. The delivery apparatus as recited in claim 1 , further comprising a heating element associated with the reservoir, the heating element being a heating coil.

8. The delivery apparatus as recited in claim 1 , wherein the lower chamber and the upper chamber are integrally formed as a single chamber.

9. The delivery apparatus as recited in claim 1 , wherein the lower chamber has a volume from about 5 ml to about 250 ml.

10. The delivery apparatus as recited in claim 1 , wherein the upper chamber has a volume from about 5 ml to about 250 ml.

11. The delivery apparatus as recited in claim 1 , further comprising a fluid circuit providing for circulation from the reservoir to the supply channel to the lower chamber to the circulation channel to the reservoir.

12. The delivery apparatus as recited in claim 1 , wherein the ultrasonic transducer further comprises a device that uses a piezoelectric transducer to produce ultrasonic waves.

13. The delivery apparatus as recited in claim 1 , wherein the ultrasonic transducer is configured to operate at 40 kHz to 2.5 MHz.

14. The delivery apparatus as recited in claim 1 , wherein the control valve further comprises a 0.2 lbs to 250 lbs pressure regulator.

15. The delivery apparatus as recited in claim 1 , wherein the source of positive pressure air further comprises an air compressor.

16. The delivery apparatus as recited in claim 1 , wherein the source of positive pressure air is configured to provides air pressure from about 0.2 psi to 25 psi.

17. A medication delivery apparatus for the application of a medical agent to a treatment site, the medication delivery apparatus comprising:

a housing;

an outer housing having a receiving chamber;

an inner housing configured to insert into the receiving chamber of the outer housing and releasably engage therewith, the inner housing thereby having an engaged position within the outer housing, the inner housing having prongs for a power connection with the outer housing;

the inner housing including a reservoir configured to contain the medical agent, the medical agent being provided in a pre-measured amount;

an upper channel being disposed in fluid communication with an airflow channel and a delivery channel, the upper channel traversing the outer housing and the inner housing in the engaged position;

an ultrasonic transducer positioned in the inner housing, the ultrasonic transducer configured to generate, upon energization, ultrasonic energy;

the inner housing and ultrasonic transducer being configured for single-use;

the outer housing, the airflow channel, the delivery channel, and a control valve being located in the housing;

the control valve being controllable by a controller, the controller being externally positioned on the housing;

a first operational state of the medication delivery apparatus wherein positive pressure air is configured to traverse the upper channel, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to be carried by the application of air to the delivery channel;

a second operational state of the medication delivery apparatus, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to remain in the inner housing; and

the control valve interposed between a source of positive pressure air and the upper channel, the control valve configured to selectively apply air to the upper channel and the delivery channel, the control valve being open in the first operational state and closed in the second operational state.

18. The medication delivery apparatus as recited in claim 17 , wherein the medical agent further comprises a local anesthetic.

19. The medication delivery apparatus as recited in claim 17 , wherein the medical agent further comprises an agent selected from the group consisting of steroids, antibiotics, anti-fungal agents, anti-bacterial agents, antiviral agents, hormones, antihistamines, non-steroidal anti-inflammatories, and glucocorticoids, corticosteroids, chemotherapeutic agents, and vasodilating anesthetics.

20. A medication delivery apparatus for the application of a medical agent to a treatment site, the medication delivery apparatus comprising:

a housing;

an outer housing having a receiving chamber;

an inner housing configured to insert into the receiving chamber of the outer housing and releasably engage therewith, the inner housing thereby having an engaged position within the outer housing, the inner housing having prongs for a power connection with the outer housing;

the inner housing including a reservoir configured to contain the medical agent, the reservoir having a volume from about 5 ml to about 250 ml, the medical agent being provided in a pre-measured amount;

an upper channel being disposed in fluid communication with an airflow channel and a delivery channel, the upper channel traversing the outer housing and the inner housing in the engaged position;

an ultrasonic transducer positioned in the inner housing, the ultrasonic transducer configured to generate, upon energization, ultrasonic energy;

the inner housing and ultrasonic transducer being configured for single-use;

the outer housing, the airflow channel, the delivery channel, and a control valve being located in the housing;

the control valve being controllable by a controller, the controller being externally positioned on the housing;

a first operational state of the medication delivery apparatus wherein positive pressure air is configured to traverse the upper channel, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to be carried by the application of air to the delivery channel;

a second operational state of the medication delivery apparatus, wherein the ultrasonic transducer is configured to apply ultrasonic energy to the medical agent, thereby producing a nebulized medical agent adapted to remain in the inner housing; and

the control valve interposed between a source of positive pressure air and the upper channel, the control valve configured to selectively apply air to the upper channel and the delivery channel, the control valve being open in the first operational state and closed in the second operational state.